ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 355

$508K Total Retail Price of All Prescriptions

Rank: 70 out of 355

514 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LEVOTHYROXINE SODIUM 658 546 97 1 6
OMEPRAZOLE 567 393 87 2 5
AMLODIPINE BESYLATE 433 375 66 3 2
ATORVASTATIN CALCIUM 421 366 67 4 4
LISINOPRIL 356 288 64 5 1
HYDROCODONE-ACETAMINOPHEN 353 241 41 S3 6 17
SIMVASTATIN 350 256 48 7 3
FUROSEMIDE 347 333 47 8 7
TRAZODONE HCL 343 305 51 9 16
METOPROLOL TARTRATE 338 271 50 10 8
LOVASTATIN 281 202 38 11 27
HYDROCHLOROTHIAZIDE 261 175 41 12 9
WARFARIN SODIUM 256 251* 27 13 10
SERTRALINE HCL 239 189 34 14 15
TRAMADOL HCL 221 203 55 15 31
ATENOLOL 190 151 31 16 11
CITALOPRAM HBR 189 117 23 17 18
NAMENDA 177 172* 12 18 25
QUETIAPINE FUMARATE 172 121 19 A 19 48
DONEPEZIL HCL 169 169 23 20 24
MONTELUKAST SODIUM 165 107 23 21 56
PAROXETINE HCL 152 98 22 22 52
ALPRAZOLAM 141 98 31 B 23 21
MIRTAZAPINE 133 128* 23 24 32
PRAVASTATIN SODIUM 131 76 24 25 14
CLONAZEPAM 114 49 15 B 26 39
LOSARTAN POTASSIUM 108 78 18 27 13
METFORMIN HCL 100 80 15 28 12
ESCITALOPRAM OXALATE 97 79 15 29 51
DIOVAN 95 <11 <11 30 37
TRIAMTERENE-HCTZ 92 50 13 31 46
GABAPENTIN 90 90 20 32 19
FLUTICASONE PROPIONATE 88 <11 18 33 35
PROAIR HFA 86 26 23 34 40
CIPROFLOXACIN HCL 84 79* 58 35 73
BUSPIRONE HCL 83 45 13 36 139
AZITHROMYCIN 82 66 62 37 64
ALENDRONATE SODIUM 81 53 14 38 23
PANTOPRAZOLE SODIUM 78 73* 17 39 33
ENULOSE 76 <11 <11 40 106
LORAZEPAM 74 53 21 B 41 30
TAMSULOSIN HCL 73 <11 <11 42 26
GLIPIZIDE XL 73 <11 <11 42 115
ADVAIR DISKUS 73 53 15 42 45
CYMBALTA 71 <11 <11 45 44
IPRATROPIUM-ALBUTEROL 70 70 20 46 88
TOPIRAMATE 66 <11 <11 47 266
RISPERIDONE 65 <11 <11 A 48 76
CLOPIDOGREL 64 59* 13 49 22
GLIPIZIDE 64 <11 <11 49 47
FLUOXETINE HCL 63 <11 <11 51 59
DIAZEPAM 63 37 12 B 51 82
METOPROLOL SUCCINATE 62 46 11 53 20
NEXIUM 59 <11 <11 54 60
MELOXICAM 58 53* 23 55 54
OXYCONTIN 56 <11 <11 S2 56 86
QUINAPRIL HCL 53 <11 <11 57 63
LOSARTAN-HYDROCHLOROTHIAZIDE 52 <11 <11 58 55
ALLOPURINOL 51 <11 <11 59 29
GLIPIZIDE ER 51 <11 <11 59 72
HYDROXYZINE HCL 50 <11 <11 R 61 167
LEVETIRACETAM 50 <11 <11 61 101
OXYBUTYNIN CHLORIDE ER 50 <11 <11 61 113
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.